JPH0545938Y2 - - Google Patents

Info

Publication number

JPH0545938Y2

JPH0545938Y2 JP17142886U JP17142886U JPH0545938Y2 JP H0545938 Y2 JPH0545938 Y2 JP H0545938Y2 JP 17142886 U JP17142886 U JP 17142886U JP 17142886 U JP17142886 U JP 17142886U JP H0545938 Y2 JPH0545938 Y2 JP H0545938Y2

Authority

JP

Japan

Prior art keywords

holding frame

skin temperature

skin

temperature measurement

liquid crystal

Prior art date

1986-11-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Lifetime

Links

• Espacenet
• Global Dossier
• Discuss

• 238000009529 body temperature measurement Methods 0.000 claims description 22
• 239000004973 liquid crystal related substance Substances 0.000 claims description 21
• BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 9
• 238000004040 coloring Methods 0.000 claims description 5
• 238000005259 measurement Methods 0.000 claims description 4
• 239000011248 coating agent Substances 0.000 claims description 3
• 238000000576 coating method Methods 0.000 claims description 3
• 230000036760 body temperature Effects 0.000 description 8
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
• 239000000463 material Substances 0.000 description 6
• 229920006267 polyester film Polymers 0.000 description 6
• HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 4
• 239000004014 plasticizer Substances 0.000 description 3
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
• 206010037660 Pyrexia Diseases 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• -1 cholesterin carboxylic acid ester Chemical class 0.000 description 2
• 239000003086 colorant Substances 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000001815 facial effect Effects 0.000 description 2
• 230000002093 peripheral effect Effects 0.000 description 2
• OTVRYZXVVMZHHW-FNOPAARDSA-N (8s,9s,10r,13r,14s,17r)-3-chloro-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1C=C2CC(Cl)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 OTVRYZXVVMZHHW-FNOPAARDSA-N 0.000 description 1
• 208000002874 Acne Vulgaris Diseases 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• CKDZWMVGDHGMFR-UHFFFAOYSA-N Buttersaeure-cholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCC)C2 CKDZWMVGDHGMFR-UHFFFAOYSA-N 0.000 description 1
• 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 description 1
• 201000005569 Gout Diseases 0.000 description 1
• CKDZWMVGDHGMFR-GTPODGLVSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] butanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCC)C1 CKDZWMVGDHGMFR-GTPODGLVSA-N 0.000 description 1
• XMPIMLRYNVGZIA-CCEZHUSRSA-N [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] [(e)-octadec-9-enyl] carbonate Chemical compound C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)OCCCCCCCC/C=C/CCCCCCCC)C2 XMPIMLRYNVGZIA-CCEZHUSRSA-N 0.000 description 1
• 206010000496 acne Diseases 0.000 description 1
• 206010003246 arthritis Diseases 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 230000003098 cholesteric effect Effects 0.000 description 1
• 150000001841 cholesterols Chemical class 0.000 description 1
• 239000002537 cosmetic Substances 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 201000010099 disease Diseases 0.000 description 1
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
• 239000013013 elastic material Substances 0.000 description 1
• 229920001971 elastomer Polymers 0.000 description 1
• 210000001061 forehead Anatomy 0.000 description 1
• 239000011521 glass Substances 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 239000000203 mixture Substances 0.000 description 1
• 208000004296 neuralgia Diseases 0.000 description 1
• 238000009659 non-destructive testing Methods 0.000 description 1
• FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
• 229920003023 plastic Polymers 0.000 description 1
• 239000004033 plastic Substances 0.000 description 1
• 239000002985 plastic film Substances 0.000 description 1
• 229920006255 plastic film Polymers 0.000 description 1
• 229920002635 polyurethane Polymers 0.000 description 1
• 239000004814 polyurethane Substances 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 238000001931 thermography Methods 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1